Subra

Subra is a biotechnology company leveraging a proprietary platform that integrates physics-based simulations with advanced machine learning to accelerate the discovery and development of novel small molecule therapeutics. The company's approach aims to overcome the limitations of traditional drug discovery by providing more accurate predictions of molecular interactions and properties. Subra focuses on challenging targets across various therapeutic areas, including oncology and immunology. By combining computational rigor with experimental validation, the company seeks to streamline the path from target identification to clinical candidates.